4-9 December, 2017 | San Antonio | SABC Symposium


 

XenTech will attend to the 2017 San Antonio Breast Cancer Symposium.

We will talk about state-of-the-art experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, with international academicians and other private physicians and researchers.

 

We are looking forward to see you there !

 

To know more about SABCS2017, it’s here.

July 2017 | ITCC-P4 official launch


XenTech is proud to be part of the ITCC-P4, a new platform to accelerate drug development for children and adolescents dying of cancer.

It has been several years since XenTech developed pediatric PDX especially liver cancer PDX. Children and adolescents cancers need to be studied since the preclinical research aside from adult cancers. At XenTech, we strongly believe that strong partnerships with other specialists in the field is the key of a successfull child cancer research.

If you want to learn more about ITCC-P4, read the Press Release

26 – 30 October 2017 | Philadelphia, USA | AACR-NCI-EORTC Conference


 

The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics will be held at the Pennsylvania Convention Center in Philadelphia, Pennsylvania, from October 26-30, 2017 with exhibit dates on October 28-29.

We will be part of companies with the latest in products and services in laboratory and clinical research!

On this special occasion, we will be glad to talk about PDX & preclinical applications: meet us at booth# 310 !See you soon #aacrncieortc2017 !

Do you want to know more about this event ? Click here.

 

 

 

July 18-20 2017 | Boston,USA | Tumor Models Congress


Xentech is pleased to announce its participation to the Boston Tumor Models Congress in July 18-20, 2017.

Our business development team will be there to answer to your questions about XenTech Tumor Models! #TMB2017

Moreover, many interesting presentations to attend, if you want to know more about the agenda, go to the website.

April 1-5th, 2017 | Washington, USA | AACR Annual Meeting


 

XenTech will be attending the 2017 AACR annual meeting in Washington. Come and visit us at booth #343 and poster sessions !

 

Poster # 3856 : Identification of circulating tumour cells in breast cancer patient-derived xenograft models

Session Date and Time: Tuesday Apr 4, 2017 8:00 AM 12:00 PM

Poster # 4936 : Modelling clinical issues by using patient-derived xenografts: Evaluation of partial hepatectomy on hepatoblastoma intrahepatic and distant growth

Session Date and Time: Tuesday Apr 4, 2017 1:00 PM – 5:00 PM

Poster # 90 : STING colocalizes with gamma-H2AX upon treatment of breast cancer cells with genotoxics: A new role in DNA repair?

Session Date and Time: Tuesday Apr 4, 2017 1:00 PM – 5:00 PM

 

 

Right after the AACR meeting, we will be heading to Massachusetts from April, 6th until April, 12th. This could be a great opportunity for us to touch base and allow us to present you our most recent models and services.

If you are interested in hearing more about our PDX expertise, set up a meeting with our dedicated team:

See you soon #AACR17 !

March 20-22nd, 2017 | Barcelona, Spain | Bio Europe Spring


XenTech is pleased to attend to the 11th BIO Europe Spring event on March in Barcelona.

It is the perfect occasion to meet you and talk about your projects in preclinical development of anti cancer drugs.

More info about this partnering conference here.

To set up a meeting with our dedicated team, send us a request:See you soon #bioeuropespring2017 !

 

March 6-8th, 2017 | Paris | Targeted Anti-Cancer Therapies Congress


Meet us at the Targeted Anti-Cancer Therpies Congress in Paris. We will talk about new molecular targets and innovative cancer therapeutics in the early phases of clinical development, supplemented by associated translational research and drug development methodology.

Do you want to know more about this event ? See the official program.

At this occasion, we will be glad to meet you, send us a request :

 

 

February 20th to 22nd, 2017 | Berlin | World ADC


Meet us at the 7th World ADC in Berlin. Lets talk about this high potential of new biopharmaceutical drugs represented by the Antibody Drug Conjugate and how preclinical studies can help you to develop and optimize them.Do you want to know more about this event ? See the official program.

At this occasion, we will be glad to discuss your ADC projects, send us a request :

 

29 november – 2 december 2016 | Munich, Germany | EORTC-NCI-AACR


EORTC-NCI-AACR 2016 2  This year in Munich is the 28th @EORTC-NCI-AACR Symposium

This event brings together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in anti cancer drug development, target selection and new discoveries in molecular biology.

We will be glad to meet you there. Come and see us at Booth C1 !

April 16-20, 2016 | New Orleans | Annual AACR meeting


AACR 2016Xentech is pleased to announce its participation to the prestigious American Association for Cancer Research (AACR) Annual Meeting 2016 in New Orleans in April 16-20, 2016.

 

Visit us at booth #1053

 

And

 

Meet our scientists at the poster sessions.

Poster # 2923 : Functional evaluation of interferon/STAT1 pathway activation in response to genotoxic treatment.

 

This year, our President & Chief Scientif officer, Jean-Gabriel Judde will make a presentation about PARPi ! Come listen to him on Tuesday 19th, 3:20pm!

 

If you want to know more about the 2016 program, go to the AACR website.